UPDATED Sep 26, 2023
Financially strong companies with expected earnings growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
NANNanosonics | AU$4.27 | -2.3% | 22.3% | AU$1.3b | AU$4.59 | PE65x | E20.9% | n/a | ||
COHCochlear | AU$258.57 | -1.0% | 28.1% | AU$16.9b | AU$238.98 | PE56.4x | E12.1% | 1.3% | ||
MVFMonash IVF Group | AU$1.28 | -0.4% | 43.3% | AU$496.8m | AU$1.33 | PE22.7x | E14.7% | 3.5% | ||
ACLAustralian Clinical Labs | AU$2.86 | 2.9% | -20.1% | AU$573.4m | AU$3.62 | PE16x | E8.8% | 4.9% |